Eckart Rüther

TL;DR: Intravenous high-dose rhEPO is well tolerated in acute ischemic stroke and associated with an improvement in clinical outcome at 1 month, and analysis of covariance controlled for these two variables indicated thatrhEPO treatment was associated with a improvement in follow-up and outcome scales.

TL;DR: It is demonstrated that peripherally applied recombinant human EPO penetrates into the brain efficiently both in rat and humans and enhances cognitive functioning in mice in the context of an aversion task involving cortical and subcortical pathways presumably affected in schizophrenia.

TL;DR: An abstinence rate of >50% in this 9-year study strongly supports the concept of comprehensive, long-term outpatient treatment of alcoholics and Supervised, guided intake of AD, also over extended periods, can be used as a predominantly psychologically acting ingredient of successful alcoholism therapy.

TL;DR: A striking remission of comorbid Axis I disorders upon abstinence during comprehensive long-term outpatient alcoholism treatment is demonstrated and the presence of an Axis II rather than an Axis I disorder on admission strongly predicts drinking outcome over a four-year follow-up.

TL;DR: A simple quantitative separation method for labelled norepinephrine and its metabolites by thin-layer chromatography on cellulose is described and the efficiency was tested by administration of drugs, which have known effects on the NE-metabolism.